Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma

NCT00242359 is registered in ClinicalTrials.gov with Bernstein Clinical Research Center as lead sponsor.

NCT NCT00242359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma
Lead sponsor
Bernstein Clinical Research Center
Phase
Phase 4
Overall status
Withdrawn
Start date
November 30, 2005
Completion date
January 31, 2009
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergy induced asthma